Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaotong,Qiu ^[1] ; Jianye,Cai ^[2] ; Haitian,Chen ^[1] ; Jia,Yao ^[2] ; Cuicui,Xiao ^[1] ; Rong,Li ^[2] ; Jiaqi,Xiao ^[1] ; Jiebin,Zhang ^[2] ; Xin,Sui ^[2] ; Tongyu,Lu ^[3] ; Jun,Zheng ^[1] ; Yingcai,Zhang ^[2] ; Yang,Yang ^[1]

作者单位： Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[1] Guangdong Province Key Laboratory of Liver Disease Research, Guangzhou, China. ^[2] Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[3] Surgical Intensive Care Unit, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[4]

关键词 chemotherapy end results database epidemiology hepatocellular carcinoma prognosis radiotherapy surveillance

DOI 10.3389/fonc.2023.1098686

PMID 37409255

发布时间 2023-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2023年13卷

1098686页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除